Abstract | AIMS: METHODS: This prospective case-control study, nested within a Japan Public Health Centre-based prospective study, included 466 participants with incident Type 2 diabetes over a 5-year period (cases) and 1361 control participants, as well as 1463 participants with existing diabetes and 1463 control participants. Eleven susceptibility single nucleotide polymorphisms, identified through genome-wide association studies and replicated in Japanese populations, were analysed. RESULTS: Most single nucleotide polymorphism loci showed directionally consistent associations with diabetes. From the combined samples, one single nucleotide polymorphism (rs2206734 at CDKAL1) reached a genome-wide significance level (odds ratio 1.28, 95% CI 1.18-1.40; P = 1.8 × 10-8 ). Three single nucleotide polymorphisms (rs2206734 in CDKAL1, rs2383208 in CDKN2A/B, and rs2237892 in KCNQ1) were nominally significantly associated with incident diabetes. Compared with the lowest quintile of the total number of risk alleles, the highest quintile had a higher odds of incident diabetes (odds ratio 2.34, 95% CI 1.59-3.46) after adjusting for conventional risk factors such as age, sex and BMI. The addition to the conventional risk factor-based model of a genetic risk score using the 11 single nucleotide polymorphisms significantly improved predictive performance; the c-statistic increased by 0.021, net reclassification improved by 6.2%, and integrated discrimination improved by 0.003. CONCLUSIONS: Our prospective findings suggest that the addition of a genetic risk score may provide modest but significant incremental predictive performance beyond that of the conventional risk factor-based model without biochemical markers.
|
Authors | A Goto, M Noda, M Goto, K Yasuda, T Mizoue, T Yamaji, N Sawada, M Iwasaki, M Inoue, S Tsugane, JPHC Study Group |
Journal | Diabetic medicine : a journal of the British Diabetic Association
(Diabet Med)
Vol. 35
Issue 5
Pg. 602-611
(05 2018)
ISSN: 1464-5491 [Electronic] England |
PMID | 29444352
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 Diabetes UK. |
Chemical References |
- C2CD4A protein, human
- CDKN2A protein, human
- CDKN2B protein, human
- Cyclin-Dependent Kinase Inhibitor p15
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclin-Dependent Kinase Inhibitor p18
- HHEX protein, human
- Homeodomain Proteins
- IGFBP2 protein, human
- IRS1 protein, human
- Insulin Receptor Substrate Proteins
- Insulin-Like Growth Factor Binding Protein 2
- KCNQ1 Potassium Channel
- KCNQ1 protein, human
- Kir6.2 channel
- Nuclear Proteins
- PPAR gamma
- Potassium Channels, Inwardly Rectifying
- TCF7L2 protein, human
- Transcription Factor 7-Like 2 Protein
- Transcription Factors
- Alpha-Ketoglutarate-Dependent Dioxygenase FTO
- FTO protein, human
- tRNA Methyltransferases
- UBE2E2 protein, human
- Ubiquitin-Conjugating Enzymes
- CDKAL1 protein, human
|
Topics |
- Adult
- Aged
- Alpha-Ketoglutarate-Dependent Dioxygenase FTO
(genetics)
- Asian People
(genetics)
- Case-Control Studies
- Cyclin-Dependent Kinase Inhibitor p15
(genetics)
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclin-Dependent Kinase Inhibitor p18
(genetics)
- Diabetes Mellitus, Type 2
(epidemiology, genetics)
- Female
- Genetic Predisposition to Disease
- Homeodomain Proteins
(genetics)
- Humans
- Incidence
- Insulin Receptor Substrate Proteins
(genetics)
- Insulin-Like Growth Factor Binding Protein 2
(genetics)
- Japan
(epidemiology)
- KCNQ1 Potassium Channel
(genetics)
- Male
- Middle Aged
- Nuclear Proteins
(genetics)
- PPAR gamma
(genetics)
- Potassium Channels, Inwardly Rectifying
(genetics)
- Prospective Studies
- Risk Assessment
- Risk Factors
- Transcription Factor 7-Like 2 Protein
(genetics)
- Transcription Factors
(genetics)
- Ubiquitin-Conjugating Enzymes
(genetics)
- tRNA Methyltransferases
(genetics)
|